retatrutide phase 2 obesity nejm 2023 jastreboff (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive + osteoarthritis data we've ever seen in the 3 TRIUMPH-4 trial: retatrutide phase 2 trial type

But before treating them, its essential to understand the difference between acne marks and acne scars because each requires a unique solution

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 17 randomised controlled trials

This package ONLY AVAILABLE after initial consultation with Dr

Li Y, Wang S, Li P, Li Y, Liu Y, Fang H, et al

#ObesityMedicine #MetabolicHealth #GLP1 #PersonalizedMedicine #Telehealth #EvidenceBasedMedicine #HealthcareInnovation #PreventiveHealth #Amply #LiveWellLiveAmply To view or add a comment, sign in The era of choosing anti-obesity medications based on individual trials is over